These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 396930)

  • 21. [Mezlocillin versus cefuroxime in urinary tract infections. A multicenter clinical study].
    Peters HJ; Weissbach L; Nuri M
    Dtsch Med Wochenschr; 1982 Oct; 107(43):1630-4. PubMed ID: 6216093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental and clinical investigations with mezlocillin in ophthalmology.
    Oishi M; Nishizuka K; Motoyama M; Ogawa T
    Arzneimittelforschung; 1979; 29(12a):1989-92. PubMed ID: 543909
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of a mezlocillin and oxacillin combination in surgery].
    Stütz G
    Med Welt; 1982 Jul; 33(26):973-7. PubMed ID: 6213833
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical pharmacology and efficacy of mezlocillin in paediatric patients with malignancy.
    Pickering LK; Kramer WG; Armes DA; Frankel LS; Townsend IR; Culbert S
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():245-50. PubMed ID: 6210674
    [No Abstract]   [Full Text] [Related]  

  • 25. Mezlocillin in neonatal infections: evaluation of efficacy and toxicity.
    Chiu T; Garrison RD; Fakhreddine F; Ayoub EM
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():251-5. PubMed ID: 6210675
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical evaluation of mezlocillin in the treatment of urinary and respiratory tract infections].
    Polubiec A; Starzyńska R; Kubica I
    Pol Tyg Lek; 1982 Jul; 37(21):617-8. PubMed ID: 6216466
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical evaluation of piperacillin therapy for infection.
    Pancoast S; Prince AS; Francke EL; Neu HC
    Arch Intern Med; 1981 Oct; 141(11):1447-50. PubMed ID: 6456708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical experience with mezlocillin in Europe-overview.
    Konopka CA; Arcieri G; Schacht P
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():267-72. PubMed ID: 6210678
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the efficacy and tolerability of mezlocillin in female patients suffering from gynaecological-obstetric infections (author's transl)].
    Weissenbacher ER; Tettenborn D
    Arzneimittelforschung; 1979; 29(12a):1999-2000. PubMed ID: 543911
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mezlocillin in the therapy of infections in renal insufficiency].
    Corlianò C; de Blasi V; Alfonso L; Aprile M; Buongiorno E; Montinaro AM; Rizzelli S; Mastrangelo F
    Clin Ter; 1982 Nov; 103(4):389-97. PubMed ID: 6217943
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative study of the effectiveness of mezlocillin and ampicillin on respiratory tract infection (author's transl].
    Kansenshogaku Zasshi; 1981 Apr; 55(4):278-324. PubMed ID: 6457072
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative effectiveness, safety and tolerance of mezlocillin and ticarcillin: a prospective randomized trail.
    Ramírez-Ronda CH; Gutiérrez J; Bermúdez RH
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():125-9. PubMed ID: 6210660
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical aspects of mezlocillin-therapy in childhood.
    Weingärtner L
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():257-62. PubMed ID: 6210676
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J; Russo ME
    Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy and tolerability of intramuscular mezlocillin in severe respiratory tract infections].
    Calvanese F; Lauriello G; Perillo G; Savastano C; Gagliardi R
    G Ital Chemioter; 1980; 27(2):97-102. PubMed ID: 6210592
    [No Abstract]   [Full Text] [Related]  

  • 36. [An open comparative study of sulbactam/ampicillin vs mezlocillin in adult and pediatric patients. Efficacy and tolerability].
    Chiodo F; Manfredi R; Zucchini A
    Minerva Med; 1991 Jun; 82(6):387-94. PubMed ID: 2067712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fixed combination mezlocillin/oxacillin injected intramuscularly. Comparative study of local tolerability compared with ampicillin and determination of effectiveness and tolerability in the treatment of surgical and urinary tract infections.
    Belli L; Freylejer A; Ginesín LM; Ríos JF; Gandolfo S
    Arzneimittelforschung; 1980; 30(10):1804-7. PubMed ID: 6449205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical experience with azlocillin].
    Baisch C; Grimm H; Schmidt D; Suhayda A
    Med Welt; 1979 Nov; 30(47):1790-3. PubMed ID: 514049
    [No Abstract]   [Full Text] [Related]  

  • 39. [Pharmacokinetics and clinical experience with 2 new penicillins: azlocillin and mezlocillin].
    Lode H; Niestrath K; Koeppe P; Langmaack H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1704-6. PubMed ID: 347796
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.